vimarsana.com

Page 30 - சீரம் நிறுவனம் ஆஃப் இந்தியா லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Coronavirus India Update: 18,000 New Infections Take Active Caseload Above 1 8 Lakh

Coronavirus India Update: 18,000 New Infections Take Active Caseload Above 1.8 Lakh Mar 06 2021, 10:33 AM March 06 2021, 10:33 AM March 06 2021, 10:33 AM Latest First March 06, 4:50 AM India reported more than 18,000 fresh cases for the first time since January amid the world’s largest inoculation drive to control its massive outbreak. Authorities detected 18,327 new cases in 24 hours, according to the Health Ministry’s update as of 8 a.m. on March 6. That’s higher than the 14,234 recoveries in the same period, taking active cases above 1.8 lakh. Daily deaths related to Covid-19, too, crossed 100 for the second straight day. Total fatalities now account for 1.41% of the nearly 1.12 crore coronavirus cases detected in the country.

Bharat Biotech s Covaxin: Criticized Indian Vaccine Already in Use Found 81% Effective

Mar 04 2021, 10:41 PM March 03 2021, 5:13 PM March 04 2021, 10:41 PM (Bloomberg) An Indian coronavirus vaccine that generated controversy when it was granted emergency approval before finishing its final stage testing has shown to provide strong protection against Covid-19 in an interim analysis of an advanced clinical trial. (Bloomberg) An Indian coronavirus vaccine that generated controversy when it was granted emergency approval before finishing its final stage testing has shown to provide strong protection against Covid-19 in an interim analysis of an advanced clinical trial. Covaxin, which was co-developed by Hyderabad-based Bharat Biotech International Ltd. and the Indian Council of Medical Research, showed an efficacy rate of 81% in those without prior infection after a second dose, the company said in a statement Wednesday. That’s better than Bharat Biotech’s guidance last year of around 60% and the country’s benchmark of 50% for vaccines targeting the

Serum s Adar Poonawalla Warns Of Delays As US Prioritizes Pfizer

US blocking raw materials will delay our vaccines, Adar Poonawalla complains to WHO

NYC Gets First J&J Shots; Italy Blocks Vaccines: Virus Update

Alabama to End Mask Mandate; NYC Gets J&J Shots: Virus Update Bloomberg 3/4/2021 Bloomberg News (Bloomberg) New York City has received its first delivery of the one-shot Johnson & Johnson vaccine, Mayor Bill de Blasio said. Governor Phil Murphy said he’s expecting a “much more normal summer” at the New Jersey shore. Connecticut announced an easing of many restrictions but will continue to require masks. Alabama will let its mask mandate expire in April. The burden from Covid-19 is weighing more heavily on hospitals in New York than anywhere else in the U.S., even as Governor Andrew Cuomo takes steps toward rolling back pandemic protections.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.